Mainz Biomed N.V.
Mainz Biomed N.V., a leading biotechnology company headquartered in Mainz, Germany, is at the forefront of developing innovative molecular diagnostics. Founded in 2021, the company focuses on enhancing early detection and treatment of gastrointestinal diseases, particularly through its proprietary products. Mainz Biomed's flagship offerings include advanced diagnostic tests that leverage cutting-edge technology to provide accurate and timely results, setting them apart in the competitive landscape. With a commitment to improving patient outcomes, the company has quickly established a strong market position, recognised for its contributions to the field of personalised medicine. As it continues to expand its operational reach across Europe and beyond, Mainz Biomed remains dedicated to pioneering solutions that address critical healthcare challenges, solidifying its role as a key player in the biotechnology industry.
DitchCarbon Score
How does Mainz Biomed N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mainz Biomed N.V.'s score of 15 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mainz Biomed N.V.'s reported carbon emissions
Mainz Biomed N.V., headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is unclear how Mainz Biomed N.V. is addressing climate change or contributing to sustainability efforts within the biotechnology sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mainz Biomed N.V. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
